Psychedelics are powerful psychoactive substances that alter consciousness and brain function. Like cannabis, psychedelics have long been considered prohibited Schedule I substances under the Controlled Substances Act of 1970. However, via the powerful psychological experiences they induce, psychedelics are now being shown to be viable therapeutic alternatives in treating depression, substance use disorders, and other mental illnesses, and even to enhance the wellbeing of healthy individuals. In May 2019, Denver, Colorado became the first city in the country to decriminalize psilocybin (the active compound in “magic mushrooms”) – we’ve now come a long way from cannabis! Join our panel of experts to learn more about the legal implications of psilocybin decriminalization and to receive an update on the current state of cannabis and industrial hemp law in Colorado.

Panelists:

Sean McAllister, McAllister Garfield, P.C.

Jean Gonnell, Gonnell Law

Adam Foster, Foster & Jones

Free CLE credit available!

Register to attend via webinar at https://attendee.gotowebinar.com/register/626718739720955407